Alphavirus replicon vectors for prophylactic applications and cancer intervention

Novel Technologies for Vaccine Development

Volumn , Issue , 2014, Pages 61-85

  Pushko, Peter ^a   Tretyakova, Irina ^a  

^a Medigen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930843059     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-1818-4_3     Document Type: Chapter

References (70)

1. Berglund P, Quesada-Rolander M, Putkonen P, Biberfeld G, Thorstensson R, Liljestrom P (1997) Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus. AIDS Res Hum Retrovir 13(17):1487-1495
2. Berglund P, Smerdou C, Fleeton MN, Tubulekas I, Liljestrom P (1998) Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol 16(6):562-565
3. Berglund P, Fleeton MN, Smerdou C, Liljestrom P (1999) Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice. Vaccine 17 (5):497-507
4. Bernstein DI, Reap EA, Katen K, Watson A, Smith K, Norberg P et al (2009) Randomized, doubleblind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine 28(2):484-493
5. Bosworth B, Erdman MM, Stine DL, Harris I, Irwin C, Jens M et al (2010) Replicon particle vaccine protects swine against influenza. Comp Immunol Microbiol Infect Dis 33(6):e99-e103
6. Cao S, Zhang W (2013) Characterization of an early-stage fusion intermediate of Sindbis virus using cryoelectron microscopy. Proc Natl Acad Sci U S A 110(33):13362-13367
7. Carrion R Jr, Bredenbeek P, Jiang X, Tretyakova I, Pushko P, Lukashevich IS (2012) Vaccine platforms to control arenaviral hemorrhagic fevers. J Vaccines Vaccin 20:3(7)
8. Carroll TD, Matzinger SR, Barro M, Fritts L, McChesney MB, Miller CJ et al (2011) Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone (R) in rhesus macaques. Vaccine 29(5):931-940
9. Chang CF, Wang M, Ou WC, Chen PL, Shen CH, Lin PY et al (2011) Human JC virus-like particles as a gene delivery vector. Expert Opin Biol Ther 11(9):1169-1175
10. Chen LH, Wilson ME (2012) Dengue and chikungunya in travelers: recent updates. Curr Opin Infect Dis 25(5):523-529
11. Dahiya SS, Saini M, Kumar P, Gupta PK (2011) An oral Sindbis virus replicon-based DNA vaccine containing VP2 gene of canine parvovirus delivered by Escherichia coli elicits immune responses in dogs. Acta Virol 55(4):289-294
12. Davis NL, Willis LV, Smith JF, Johnston RE (1989) In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virology 171(1):189-204
13. Davis NL, Grieder FB, Smith JF, Greenwald GF, Valenski ML, Sellon DC et al (1994) A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis. Arch Virol Suppl 9:99-109
14. Davis NL, Brown KW, Johnston RE (1996) A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J Virol 70(6):3781-3787
15. Dubensky TW Jr, Driver DA, Polo JM, Belli BA, Latham EM, Ibanez CE et al (1996) Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol 70(1):508-519
16. Eriksson M, Andreasson K, Weidmann J, Lundberg K, Tegerstedt K, Dalianis T et al (2011) Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor. PLoS One 6(8):e23828
17. Frolov I, Hoffman TA, Pragai BM, Dryga SA, Huang HV, Schlesinger S et al (1996) Alphavirusbased expression vectors: strategies and applications. Proc Natl Acad Sci U S A 93(21):11371-11377
18. Frolov I, Frolova E, Schlesinger S (1997) Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA. J Virol 71(4):2819-2829
19. Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB (2002) Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis 8(5):503-507
20. Gibbons DL, Vaney MC, Roussel A, Vigouroux A, Reilly B, Lepault J et al (2004) Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 427(6972):320-325
21. Hahn CS, Hahn YS, Braciale TJ, Rice CM (1992) Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc Natl Acad Sci U S A 89 (7):2679-2683
22. Herbert AS, Kuehne AI, Barth JF, Ortiz RA, Nichols DK, Zak SE et al (2013) Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus. J Virol 87(9):4952-4964
23. Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A (1998) Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology 251(1):28-37
24. Johanning FW, Conry RM, LoBuglio AF, Wright M, Sumerel LA, Pike MJ et al (1995) A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo. Nucleic Acids Res 23(9):1495-1501
25. Johansson DX, Ljungberg K, Kakoulidou M, Liljestrom P (2012) Intradermal electroporation of naked replicon RNA elicits strong immune responses. PLoS One 7(1):e29732
26. Kamrud KI, Alterson KD, Andrews C, Copp LO, Lewis WC, Hubby B et al (2008) Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats. PLoS One 3(7): e2709
27. Kielian M (2010) Structural biology: an alphavirus puzzle solved. Nature 468(7324):645-646
28. Knudsen ML, Mbewe-Mvula A, Rosario M, Johansson DX, Kakoulidou M, Bridgeman A et al (2012) Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine. J Virol 86(8):4082-4090
29. Liljestrom P, Garoff H (1991) A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology 9(12):1356-1361
30. Loy JD, Gander J, Mogler M, Vander Veen R, Ridpath J, Harris DH et al (2013) Development and evaluation of a replicon particle vaccine expressing the E2 glycoprotein of bovine viral diarrhea virus (BVDV) in cattle. Virol J 10:35
31. Mossman SP, Bex F, Berglund P, Arthos J, O'Neil SP, Riley D et al (1996) Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol 70(3):1953-1960
32. Muniz AE (2012) Venezuelan equine encephalitis in a teenager visiting Central America. Pediatr Emerg Care 28(4):372-375
33. Nelson EL, Prieto D, Alexander TG, Pushko P, Lofts LA, Rayner JO et al (2003) Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the 'self' tumor-associated antigen, neu in a rat mammary tumor model. Breast Cancer Res Treat 82(3):169-183
34. Nishimoto KP, Laust AK, Wang K, Kamrud KI, Hubby B, Smith JF et al (2007) Restricted and selective tropism of a Venezuelan equine encephalitis virus-derived replicon vector for human dendritic cells. Viral Immunol 20(1):88-104
35. Osada T, Morse MA, Hobeika A, Lyerly HK (2012) Novel recombinant alphaviral and adenoviral vectors for cancer immunotherapy. Semin Oncol 39(3):305-310
36. Paredes AM, Brown DT, Rothnagel R, Chiu W, Schoepp RJ, Johnston RE et al (1993) Threedimensional structure of a membrane-containing virus. Proc Natl Acad Sci U S A 90 (19):9095-9099
37. Petrakova O, Volkova E, Gorchakov R, Paessler S, Kinney RM, Frolov I (2005) Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells. J Virol 79(12):7597-7608
38. Pijlman GP, Suhrbier A, Khromykh AA (2006) Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications. Expert Opin Biol Ther 6(2):135-145
39. Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF (1997) Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239(2):389-401
40. Pushko P, Bray M, Ludwig GV, Parker M, Schmaljohn A, Sanchez A et al (2000) Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19(1):142-153
41. Pushko P, Geisbert J, Parker M, Jahrling P, Smith J (2001) Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol 75(23):11677-11685
42. Schafer A, Whitmore AC, Konopka JL, Johnston RE (2009) Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis. J Virol 83(9):4275-4286
43. Schwartz O, Albert ML (2010) Biology and pathogenesis of chikungunya virus. Nat Rev 8(7):491-500
44. Seregin AV, Yun NE, Poussard AL, Peng BH, Smith JK, Smith JN et al (2010) TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs. Vaccine 28(30):4713-4718
45. Slovin SF, Kehoe M, Durso R, Fernandez C, Olson W, Gao JP et al (2013) A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer. Vaccine 31(6):943-949
46. Strauss JH, Strauss EG (1994) The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 58(3):491-562
47. Sun Y, Tian DY, Li S, Meng QL, Zhao BB, Li Y et al (2013) Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever. Vaccine 31(3):538-544
48. Tegerstedt K, Franzen AV, Andreasson K, Joneberg J, Heidari S, Ramqvist T et al (2005) Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer. Anticancer Res 25(4):2601-2608
49. Thompson JM, Whitmore AC, Konopka JL, Collier ML, Richmond EM, Davis NL et al (2006) Mucosal and systemic adjuvant activity of alphavirus replicon particles. Proc Natl Acad Sci U S A 103(10):3722-3727
50. Thompson JM, Whitmore AC, Staats HF, Johnston RE (2008) Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen. Vaccine 26(33):4267-4275
51. Tretyakova I, Lukashevich IS, Glass P, Wang E, Weaver S, Pushko P (2013) Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. Vaccine 31(7):1019-1025
52. Vancini R, Wang G, Ferreira D, Hernandez R, Brown DT (2013) Alphavirus genome delivery occurs directly at the plasma membrane in a time-and temperature-dependent process. J Virol 87(8):4352-4359
53. Vander Veen RL, Harris DL, Kamrud KI (2012) Alphavirus replicon vaccines. Animal Health Research Reviews/Conference of Research Workers in Animal Diseases 13(1):1-9
54. Vaney MC, Duquerroy S, Rey FA (2013) Alphavirus structure: activation for entry at the target cell surface. Curr Opin Virol 3(2):151-158
55. Vasilakis N, Falvey D, Gangolli SS, Coleman J, Kowalski J, Udem SA et al (2003) Transfectionindependent production of alphavirus replicon particles based on poxvirus expression vectors. Nat Biotechnol 21(8):932-935
56. Vasilevska J, Skrastina D, Spunde K, Garoff H, Kozlovska T, Zajakina A (2012) Semliki Forest virus biodistribution in tumor-free and 4T1 mammary tumor-bearing mice: a comparison of transgene delivery by recombinant virus particles and naked RNA replicon. Cancer Gene Ther 19(8):579-587
57. Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E et al (2010) Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 468(7324):709-712
58. Wahlberg JM, Garoff H (1992) Membrane fusion process of Semliki Forest virus. I: Low pH-induced rearrangement in spike protein quaternary structure precedes virus penet rationinto cells. J Cell Biol 116(2):339-348
59. Wahlberg JM, Boere WA, Garoff H (1989) The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation. J Virol 63(12):4991-4997
60. Wecker M, Gilbert P, Russell N, Hural J, Allen M, Pensiero M et al (2012) Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults. Clin Vaccine Immunol 19(10):1651-1660
61. Werblow A, Bolius S, Dorresteijn AW, Melaun C, Klimpel S (2013) Diversity of Culex torrentium Martini, 1925-a potential vector of arboviruses and filaria in Europe. Parasitol Res 112 (7):2495-2501
62. White LJ, Sariol CA, Mattocks MD, Wahala MPBW, Yingsiwaphat V, Collier ML et al (2013) An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection. J Virol 87(6):3409-3424
63. Williamson C, Morris L, Maughan MF, Ping LH, Dryga SA, Thomas R et al (2003) Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res Hum Retrovir 19(2):133-144
64. Wolf A, Hodneland K, Frost P, Braaen S, Rimstad E (2013) A hemagglutinin-esterase-expressing salmonid alphavirus replicon protects Atlantic salmon (Salmo salar) against infectious salmon anemia (ISA). Vaccine 31(4):661-669
65. Xiong C, Levis R, Shen P, Schlesinger S, Rice CM, Huang HV (1989) Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science (New York, NY) 243 (4895):1188-1191
66. Yu YZ, Guo JP, An HJ, Zhang SM, Wang S, Yu WY et al (2013) Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors. Vaccine 31(20):2427-2432
67. Zhang X, Fugere M, Day R, Kielian M (2003) Furin processing and proteolytic activation of Semliki Forest virus. J Virol 77(5):2981-2989
68. Zhang R, Hryc CF, Cong Y, Liu X, Jakana J, Gorchakov R et al (2011) 4.4 A cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. EMBO J 30(18):3854-3863
69. Zhou X, Berglund P, Zhao H, Liljestrom P, Jondal M (1995) Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proc Natl Acad Sci U S A 92(7):3009-3013
70. Zhu W, Fu J, Lu J, Deng Y, Wang H, Wei Y et al (2013) Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbislike virus XJ-160. Arch Virol 158(5):1013-1019